Innovation
19 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 331 times.
| Year | Filings |
|---|---|
| 2024 | 8 |
| 2025 | 10 |
| 2026 | 6 |
Social engagement
Social engagement: 5.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
5 investors on record; lead investors include Colt Ventures, Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Private equity | 2 | 40% |
Recent activity
26 Feb 2026
Event
TD Cowen 46th Annual Health Care Conference and Leerink Partners Global Healthcare Conference
2 Feb 2026
Leadership hire
Chief Medical Officer
4 Dec 2025
Product launch
ALTA2618